Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2021-01-09 Notice of Dividend Amou…
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Gulf Pharmaceutical Industries Announcements
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding outstanding cash dividends for shareholders, providing instructions on how to claim unpaid dividends and mentioning a deadline after which dividends will be transferred to the regulatory authority. It does not contain financial statements, results, or detailed report data. The document is short (2010 characters) and serves as a notification to shareholders about dividend payments. Therefore, it fits the category of Notice of Dividend Amount (DIV), as it relates to dividend payment information and instructions.
2021-01-09 English
شركة الخليج للصناعات الدوائية النتائج المالية للفترة المنتهية في 30 سبتمبر,2019
Regulatory Filings
2019-11-13 Arabic
Gulf Pharmaceutical Industries Financial Results for the Period Ended September 30,2019
Regulatory Filings
2019-11-13 English
شركة الخليج للصناعات الدوائية بيان صحفي عن النتائج المالية للفترة المنتهية في 30 سبتمبر,2019
Earnings Release Classification · 95% confidence The document is a press release announcing the third quarter financial results for the year 2019 of Julphar, a pharmaceutical company. It includes financial figures such as net sales and net losses for the quarter, mentions management changes, and discusses operational and strategic updates. The document is relatively short (3012 characters) and focuses on summarizing quarterly financial performance and company outlook. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights. It is not a full interim report with detailed financial statements, nor is it an announcement of a report publication. Therefore, the correct classification is ER with high confidence. 9M 2019
2019-11-13 Arabic
Gulf Pharmaceutical Industries Press Release on the Financial Results for the Period Ended September 30,2019
Earnings Release Classification · 95% confidence The document is a press release announcing Julphar's financial results for the third quarter of 2019. It provides summary financial data such as net sales and net loss, discusses operational impacts, management changes, and outlook commentary. The document is relatively short (3358 characters) and does not contain detailed financial statements or comprehensive financial analysis. It is an initial announcement of quarterly financial results rather than a full interim or quarterly report. Therefore, it fits the definition of an Earnings Release (ER). Q3 2019
2019-11-13 English
شركة الخليج للصناعات الدوائية تقرير عن الخسائر المتراكمة 30 سبتمبر,2019
Regulatory Filings
2019-11-13 Arabic

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.